Published • loading... • Updated
New Pancreatic Cancer Pill Priced at $480,000 per Year
Summary by KTLA 5
4 Articles
4 Articles
New pancreatic cancer pill priced at $480,000 per year
A new pancreatic cancer drug is carrying a price tag that may shock you -- $480,000 per year. Most consumer products are priced to recover R&D and production costs, plus a reasonable profit. But not prescription drugs. A good case in point is a new cancer drug called Rasonque from Revolution Medicines. This drug is [...]
·Los Angeles, United States
Read Full Article
Reason, the new treatment against pancreatic cancer of Revolution Medicines, illustrates the strong high prices of anticancer drugs in the last two decades The post Pill of R$ 2.4 mi per year shows the new normal price of cancer remedies appeared first on InfoMoney.
Coverage Details
Total News Sources4
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
